1. Home
  2. FKWL vs GANX Comparison

FKWL vs GANX Comparison

Compare FKWL & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FKWL
  • GANX
  • Stock Information
  • Founded
  • FKWL 1981
  • GANX 2017
  • Country
  • FKWL United States
  • GANX United States
  • Employees
  • FKWL N/A
  • GANX N/A
  • Industry
  • FKWL Telecommunications Equipment
  • GANX Biotechnology: Pharmaceutical Preparations
  • Sector
  • FKWL Utilities
  • GANX Health Care
  • Exchange
  • FKWL Nasdaq
  • GANX Nasdaq
  • Market Cap
  • FKWL 35.5M
  • GANX 31.5M
  • IPO Year
  • FKWL 1996
  • GANX 2021
  • Fundamental
  • Price
  • FKWL $4.05
  • GANX $1.22
  • Analyst Decision
  • FKWL
  • GANX Strong Buy
  • Analyst Count
  • FKWL 0
  • GANX 4
  • Target Price
  • FKWL N/A
  • GANX $8.25
  • AVG Volume (30 Days)
  • FKWL 23.3K
  • GANX 347.4K
  • Earning Date
  • FKWL 07-02-2024
  • GANX 08-08-2024
  • Dividend Yield
  • FKWL N/A
  • GANX N/A
  • EPS Growth
  • FKWL N/A
  • GANX N/A
  • EPS
  • FKWL N/A
  • GANX N/A
  • Revenue
  • FKWL $41,683,786.00
  • GANX N/A
  • Revenue This Year
  • FKWL N/A
  • GANX $1,009.10
  • Revenue Next Year
  • FKWL N/A
  • GANX N/A
  • P/E Ratio
  • FKWL N/A
  • GANX N/A
  • Revenue Growth
  • FKWL 1.45
  • GANX N/A
  • 52 Week Low
  • FKWL $2.69
  • GANX $1.11
  • 52 Week High
  • FKWL $4.16
  • GANX $5.33
  • Technical
  • Relative Strength Index (RSI)
  • FKWL 84.07
  • GANX 38.12
  • Support Level
  • FKWL $3.45
  • GANX $1.22
  • Resistance Level
  • FKWL $3.53
  • GANX $1.32
  • Average True Range (ATR)
  • FKWL 0.11
  • GANX 0.09
  • MACD
  • FKWL 0.04
  • GANX 0.06
  • Stochastic Oscillator
  • FKWL 93.62
  • GANX 44.83

About FKWL Franklin Wireless Corp.

Franklin Wireless Corp is a provider of wireless solutions, including mobile hotspots, routers, and modems, as well as hardware and software products that support machine-to-machine (M2M) applications and the Internet of Things (IoT). Its M2M and IoT solutions include embedded modules, modems, and gateways built to deliver reliable always-on connectivity supporting a spectrum of applications. These products are designed to solve wireless connectivity challenges in a range of vertical markets, including video surveillance, digital signage, home security, oil and gas exploration, kiosks, fleet management, smart grid, vehicle diagnostics, and telematics.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across, several therapeutics areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. The company derives revenues from collaboration and licensing agreements.

Share on Social Networks: